Cyclo Therapeutics Inc. (CYTH)
NASDAQ: CYTH
· Real-Time Price · USD
0.72
-0.00 (-0.08%)
At close: Mar 25, 2025, 3:59 PM
Cyclo Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.64 | -1.44 | -2.24 | -1.75 | -1.2 | -1.2 | -0.46 | -0.62 | -0.96 | -1.2 | 0.00 | -2.15 | -2.82 | -4.53 | -2.71 |
PEG Ratio | -0.01 | -0.04 | 0.06 | 0.08 | 0.10 | 0.04 | 0.02 | -0.04 | -0.04 | 0.01 | -0.00 | 0.08 | -0.39 | 0.17 | -0.05 |
PS Ratio | 96.96 | 279.17 | 192.03 | 126.98 | 46.40 | 190.64 | 60.65 | 64.33 | 36.06 | 30.63 | 136.81 | 41.10 | 107.75 | 273.04 | 122.27 |
PB Ratio | -1.68 | -6.71 | 63.73 | 8.31 | -21.84 | -15.04 | -21.06 | 16.36 | 2.90 | 1.70 | 2.04 | 1.53 | 5.71 | 5.86 | 3.06 |
P/FCF Ratio | -1.88 | -8.93 | -6.29 | -9.2 | -5.69 | -6.42 | -2.11 | -4.4 | -5.11 | -3.81 | -5.52 | -9.29 | -14.38 | -14.6 | -8.89 |
P/OCF Ratio | -2.77 | -8.93 | -6.29 | -9.21 | -5.69 | -6.42 | -2.11 | -4.37 | -5.12 | -3.81 | -5.52 | -9.21 | -14.38 | -14.67 | -8.89 |
OCF/S Ratio | -35.04 | -31.26 | -30.54 | -13.79 | -8.16 | -29.7 | -28.67 | -14.7 | -7.04 | -8.04 | -24.78 | -4.46 | -7.49 | -18.61 | -13.76 |
Debt / Equity Ratio | -0.91 | -0.59 | 1.09 | 0.22 | -0.04 | -0.03 | -0.12 | n/a | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 |
Quick Ratio | 0.16 | 0.43 | 0.97 | 1.42 | 0.80 | 0.71 | 0.83 | 1.12 | 2.83 | 5.48 | 5.43 | 5.01 | 3.14 | 4.56 | 4.79 |
Current Ratio | 0.17 | 0.45 | 1.01 | 1.45 | 0.83 | 0.75 | 0.89 | 1.19 | 2.93 | 5.60 | 5.51 | 5.07 | 3.21 | 4.65 | 4.86 |
Asset Turnover | 0.04 | 0.03 | 0.03 | 0.02 | 0.09 | 0.03 | 0.04 | 0.04 | 0.05 | 0.05 | 0.01 | 0.03 | 0.04 | 0.02 | 0.02 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -26.88 | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a |
Return on Equity | 0.66 | 1.17 | -7.12 | -1.19 | 4.53 | 3.12 | 11.41 | -6.55 | -0.76 | -0.35 | 12.48K | -0.18 | -0.51 | -0.32 | -0.28 |
Return on Assets | -1.68 | -1.27 | -0.61 | -0.43 | -0.85 | -1 | -1.22 | -1.14 | -0.5 | -0.29 | 10.23K | -0.14 | -0.35 | -0.25 | -0.22 |
Return on Invested Capital | 6.54 | 2.65 | -4.01 | -0.83 | 4.82 | 3.27 | 13.59 | -6.54 | -0.76 | -0.35 | 13.19K | -0.18 | -0.49 | -0.32 | -0.28 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.93 | -6.56 | -3.13 | -1.81 | 0.92 | 0.83 | 0.93 | 0.92 | 0.93 | 0.86 | 0.92 | 0.88 | 0.94 | 0.87 | 0.90 |
Net Profit Margin | -37.78 | -48.59 | -21.45 | -18.12 | -9.63 | -39.59 | -32.85 | -25.75 | -9.39 | -6.36 | 835.61K | -4.77 | -9.56 | -15.08 | -11.27 |
Pretax Profit Margin | -37.78 | -48.59 | -21.45 | -18.12 | -9.63 | -39.59 | -32.85 | -26.66 | -9.39 | -6.37 | -14.22 | -4.77 | -9.56 | -15.08 | -11.27 |
Operating Profit Margin | -35.46 | -45.78 | -25.24 | -18.12 | -9.62 | -39.56 | -32.85 | -26.62 | -9.4 | -6.38 | -15.06 | -4.77 | -9.55 | -15.09 | -11.27 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -35.45 | -45.78 | -25.23 | -18.1 | -9.61 | -39.52 | -32.82 | -26.65 | -9.38 | -6.37 | -15.03 | -4.77 | -9.54 | -15.07 | -11.26 |